BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 19318509)

  • 1. Assessment of serum inflammatory parameters in RRMS and SPMS patients.
    Nowak-Kiczmer M; Niedziela N; Czuba ZP; Sowa P; Wierzbicki K; Lubczyński M; Adamczyk-Sowa M
    Neurol Res; 2024 Jun; 46(6):495-504. PubMed ID: 38697017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of combined functional resistance and endurance exercise over 12 weeks on matrix metalloproteinase-2 serum concentration in persons with relapsing-remitting multiple sclerosis - a community-based randomized controlled trial.
    Proschinger S; Joisten N; Rademacher A; Schlagheck ML; Walzik D; Metcalfe AJ; Oberste M; Warnke C; Bloch W; Schenk A; Bansi J; Zimmer P
    BMC Neurol; 2019 Dec; 19(1):314. PubMed ID: 31810462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance training modifies of serum levels of matrix metalloproteinase 2 and tissue inhibitor of matrix metalloproteinases in multiple sclerosis women - a randomized controlled trail.
    Nezhad NN; Parnow A; Khamoushian K; Eslami R; Baker JS
    BMC Neurosci; 2024 Mar; 25(1):13. PubMed ID: 38438999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Related Differences of Matrix Metalloproteinases (MMPs): New Perspectives for These Biomarkers in Cardiovascular and Neurological Diseases.
    Trentini A; Manfrinato MC; Castellazzi M; Bellini T
    J Pers Med; 2022 Jul; 12(8):. PubMed ID: 35893290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases.
    Cabral-Pacheco GA; Garza-Veloz I; Castruita-De la Rosa C; Ramirez-Acuña JM; Perez-Romero BA; Guerrero-Rodriguez JF; Martinez-Avila N; Martinez-Fierro ML
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33419373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "
    Gemmati D; Varani K; Bramanti B; Piva R; Bonaccorsi G; Trentini A; Manfrinato MC; Tisato V; Carè A; Bellini T
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31906252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients.
    Castellazzi M; Ligi D; Contaldi E; Quartana D; Fonderico M; Borgatti L; Bellini T; Trentini A; Granieri E; Fainardi E; Mannello F; Pugliatti M
    Front Neurol; 2018; 9():1080. PubMed ID: 30619040
    [No Abstract]   [Full Text] [Related]  

  • 8. Vaginal Lactoferrin Modulates PGE
    Trentini A; Maritati M; Cervellati C; Manfrinato MC; Gonelli A; Volta CA; Vesce F; Greco P; Dallocchio F; Bellini T; Contini C
    Mediators Inflamm; 2016; 2016():3648719. PubMed ID: 27872513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating Soluble EMMPRIN as a Marker of Disease Activity in Multiple Sclerosis: Studies of Serum and Cerebrospinal Fluid.
    Kaushik DK; Yong HY; Hahn JN; Silva C; Casha S; Hurlbert RJ; Jacques FH; Lisak R; Khan O; Ionete C; Larochelle C; Prat A; Bar-Or A; Yong VW
    PLoS One; 2016; 11(10):e0163802. PubMed ID: 27727297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients.
    Trentini A; Castellazzi M; Cervellati C; Manfrinato MC; Tamborino C; Hanau S; Volta CA; Baldi E; Kostic V; Drulovic J; Granieri E; Dallocchio F; Bellini T; Dujmovic I; Fainardi E
    Dis Markers; 2016; 2016():3672353. PubMed ID: 27555667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy.
    Castellazzi M; Bellini T; Trentini A; Delbue S; Elia F; Gastaldi M; Franciotta D; Bergamaschi R; Manfrinato MC; Volta CA; Granieri E; Fainardi E
    Dis Markers; 2016; 2016():8434209. PubMed ID: 27340316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiogenesis in multiple sclerosis and experimental autoimmune encephalomyelitis.
    Girolamo F; Coppola C; Ribatti D; Trojano M
    Acta Neuropathol Commun; 2014 Jul; 2():84. PubMed ID: 25047180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The significance of matrix metalloproteinases in the immunopathogenesis and treatment of multiple sclerosis.
    Mirshafiey A; Asghari B; Ghalamfarsa G; Jadidi-Niaragh F; Azizi G
    Sultan Qaboos Univ Med J; 2014 Feb; 14(1):e13-25. PubMed ID: 24516744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinases, new insights into the understanding of neurodegenerative disorders.
    Kim YS; Joh TH
    Biomol Ther (Seoul); 2012 Mar; 20(2):133-43. PubMed ID: 24116286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding.
    Rizzo R; Trentini A; Bortolotti D; Manfrinato MC; Rotola A; Castellazzi M; Melchiorri L; Di Luca D; Dallocchio F; Fainardi E; Bellini T
    Mol Cell Biochem; 2013 Sep; 381(1-2):243-55. PubMed ID: 23737137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imbalances between matrix metalloproteinases (MMPs) and tissue inhibitor of metalloproteinases (TIMPs) in maternal serum during preterm labor.
    Tency I; Verstraelen H; Kroes I; Holtappels G; Verhasselt B; Vaneechoutte M; Verhelst R; Temmerman M
    PLoS One; 2012; 7(11):e49042. PubMed ID: 23145060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Tamborino C; Trentini A; Manfrinato MC; Baldi E; Tola MR; Dallocchio F; Granieri E; Bellini T
    Mult Scler; 2009 May; 15(5):547-54. PubMed ID: 19318509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis.
    Benesová Y; Vasku A; Novotná H; Litzman J; Stourac P; Beránek M; Kadanka Z; Bednarík J
    Mult Scler; 2009 Mar; 15(3):316-22. PubMed ID: 19153173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis.
    Fainardi E; Castellazzi M; Bellini T; Manfrinato MC; Baldi E; Casetta I; Paolino E; Granieri E; Dallocchio F
    Mult Scler; 2006 Jun; 12(3):294-301. PubMed ID: 16764342
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.